Well I also like the fact that important trials and FDA registration assessments are underway or about to start for View5.
Premises are fortuitously in a configuration that allows production to continue despite Covid.
They have receipts from CZM for maybe 5 new convivo scopes.
No doubt it will be greeted with the usual howls of derision from a certain quarter, but it looks good to me.
Ann: OIL December 2020 Quarterly Report and Appendix 4C, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.010(5.71%) |
Mkt cap ! $137.8M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 16.5¢ | $16.50K | 97.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 168328 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 25000 | 1 |
View Market Depth
| Last trade - 11.27am 04/10/2024 (20 minute delay) ? |
| OIL (ASX) Chart |